市場調查報告書
商品編碼
1413850
人工授精市場 - 2024-2030 年全球預測Artificial Insemination Market - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年人工授精市場規模為31.7億美元,預計2024年將達34.2億美元,2030年將達54.9億美元,複合年成長率為8.16%。
世界人工授精市場
主要市場統計 | |
---|---|
基準年[2023] | 31.7億美元 |
預測年份 [2024] | 34.2億美元 |
預測年份 [2030] | 54.9億美元 |
複合年成長率(%) | 8.16% |
人工授精是指將精子直接輸送到女性生殖道的不孕症治療方法。這項技術涉及一種醫療程序,透過人工方式而不是透過自然交配將來自伴侶或捐贈者的精子插入女性的子宮頸、子宮腔或輸卵管。近年來,與無精子症或精子數量極少有關的幾種男性不孕問題以及與 Y 染色體有關的遺傳性疾病的患病率有所增加,導致需要人工授精來幫助受孕。發生。此外,隨著中產階級人口的不斷成長,新興經濟體不孕症服務的擴展也擴大了人工授精技術的範圍和應用。然而,人工授精程序的複雜性和成功率低,再加上熟練人員的缺乏,阻礙了該行業的發展。此外,與人工授精相關的一些倫理和安全問題引起了人們對該技術的可靠性和可接受性的擔憂。然而,家庭人工授精和不孕症治療套件的核准標誌著人工授精市場的有利法規環境,有助於抵消道德和安全限制方面的挑戰。領先企業也正在探索開發排卵預測的非侵入性方法來最佳化人工授精時機,以及融合人工智慧技術對人工授精成功率進行預測分析。
區域洞察
美洲,特別是美國和加拿大,擁有強大的醫療基礎設施,包括多種不孕症治療服務報銷系統。此外,不斷變化的社會文化趨勢,例如對維持生殖健康重要性的認知、對人工授精服務可用性的認知以及晚婚,進一步增加了對生殖技術的需求。歐盟國家對人工授精的需求和行為有不同程度的特點,其中許多受到當地法規和文化態度的影響。一些歐盟國家處於生殖研究投資的前沿,也支持了市場擴張。在亞太地區,印度、中國和日本等國家提供政府支援政策,以促進人工授精技術的採用。在中國,由於不孕率上升和一胎政策的放寬,人工授精的需求正在迅速擴大。
FPNV定位矩陣
FPNV定位矩陣對於評估人工授精市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對人工授精市場供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴考察,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,從而在市場上獲得競爭優勢。
1-市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2-市場開拓:我們深入研究利潤豐厚的新興市場,並分析它們在成熟細分市場中的滲透率。
3- 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。
4-競爭力評估與資訊:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。
5- 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。
1-人工授精市場的市場規模與預測是多少?
2-人工授精市場預測期間需要考慮投資的產品、細分市場、應用和領域有哪些?
3-人工授精市場的技術趨勢和法律規範是什麼?
4-人工授精市場主要供應商的市場佔有率為何?
5-進入人工授精市場合適的型態和策略手段有哪些?
[187 Pages Report] The Artificial Insemination Market size was estimated at USD 3.17 billion in 2023 and expected to reach USD 3.42 billion in 2024, at a CAGR 8.16% to reach USD 5.49 billion by 2030.
Global Artificial Insemination Market
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 3.17 billion |
Estimated Year [2024] | USD 3.42 billion |
Forecast Year [2030] | USD 5.49 billion |
CAGR (%) | 8.16% |
Artificial insemination refers to a fertility treatment method used to deliver sperm directly into the female reproductive tract. This technique involves a medical procedure where sperm, either from a partner or donor, is inserted into a woman's cervix, uterine cavity, or fallopian tubes using artificial means rather than by natural copulation. In recent years, several male infertility issues related to azoospermia or very low sperm count and the prevalence of inherited genetic diseases linked to the Y-chromosome are increasing, creating the need for artificial insemination to help conceive. Additionally, the expansion of fertility services in emerging economies with growing middle-class populations has also extended the scope and application of artificial insemination technologies. However, procedural complexities and the low success rate of artificial insemination, coupled with a lack of skilled personnel, impede the growth of the industry. Additionally, several ethical and safety issues related to artificial insemination raise concerns about the reliability and acceptability of the technology. However, approvals for at-home artificial insemination and fertility kits signal a positive regulatory environment for the artificial insemination market, thereby helping offset challenges related to ethical and safety constraints. Key players are also exploring the development of non-invasive methods for ovulation prediction to optimize timing for artificial insemination and the integration of artificial intelligence techniques for predictive analytics of the success rate of artificial insemination.
Regional Insights
The Americas region, particularly the US and Canada, boasts of a robust healthcare infrastructure, with several reimbursement plans for fertility services. Additionally, recognition of the importance of maintaining reproductive health, awareness about the availability of artificial insemination services, and evolving socio-cultural trends, such as the tendency to have children later in life, have further cemented the need for reproductive technologies. EU countries are characterized by varying degrees of need and behavior around artificial insemination, largely influenced by local regulations and cultural attitudes. Several EU nations are at the forefront of investing in reproductive research, which also supports the market expansion. In APAC, nations such as India, China, and Japan provide supportive government policies to promote the adoption of artificial insemination technologies. China's need for artificial insemination has rapidly expanded due to increasing infertility rates and the relaxation of the one-child policy.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Artificial Insemination Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Artificial Insemination Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Artificial Insemination Market, highlighting leading vendors and their innovative profiles. These include Conceivex Inc., Femasys Inc., Fujifilm Irvine Scientific, Hamilton Thorne, IMV Technologies, INVO Bioscience, Mosie Baby, Pride Angel, Rinovum Women's Health Company, and Vitrolife AB.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Artificial Insemination Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Artificial Insemination Market?
3. What are the technology trends and regulatory frameworks in the Artificial Insemination Market?
4. What is the market share of the leading vendors in the Artificial Insemination Market?
5. Which modes and strategic moves are suitable for entering the Artificial Insemination Market?